U.S. Launch of Royal Biologics BIOINCYTE PRFM
BIOINCYTE is a next-generation autologous fibrin and platelet system that converts traditional PRP to platelet rich fibrin matrix formulations....
Feb 14, 2023,
U.S. Launch of Royal Biologics BIOINCYTE PRFM
First Cases with Anika RevoMotion Reverse Shoulder
RevoMotion reportedly offers the smallest diameter threaded glenoid baseplate, which preserves bone and enhances intraoperative flexibility....
Feb 13, 2023,
Catalyst Granted 510(k) for Convertible Stemmed Total Shoulder
Catalyst OrthoScience is reportedly the first to market with a fully convertible system that features an ellipsoid anatomic head....
Feb 09, 2023,
Eminent Spine Gains 510(k) for Cervical Interbody
Eminent Spine's Cervical IBFD includes PEEK, titanium and 3D-printed titanium. The implants are offered as non-sterile....
Feb 09, 2023,
Globus Medical to Acquire NuVasive for $3.1 Billion
The combines will combine in an all-stock merger to create the 7th largest orthopedic company overall and 2nd largest spine...
Feb 09, 2023,
OSSIO Launches Non-Permanent OSSIOfiber Compression Staple
OSSIOfiber Compression Staples are reportedly the first and only bio-integrative orthopedic compression staple in the world....
Feb 08, 2023,
Early Results with Kleiner Labs’ KG2 Surge Interbody
Kleiner Device Labs found that surgeons were able to deliver an average of 12cc of bone graft into the prepared...
Feb 08, 2023,
CONMED Suffers Self-Inflicted Wound to End 2022
The company's organic orthopedic sales declined slightly in 2022 as a faulty software implementation hampered 4Q sales....
Feb 07, 2023,
Zimmer Biomet’s Priority Markets Drove 2022 Growth
The company grew in the mid-single digits for 2022 when excluding the impact of foreign currency translation....
Feb 06, 2023,
Naviswiss Gains FDA 510(k) Clearance for Naviswiss Knee
The Naviswiss Knee is a landmark-based navigation application that assists the surgeon in optimal positioning and alignment of knee implants....
Feb 06, 2023,
Loading new posts...
No more posts
